Hi! I'M Mildred Jiménez: venture builder and impact investor working at the intersection of biotechnology, climate innovation, and social impact.
My Value Add
My background in venture building, investment, and deep technical training gives me a perspective that few VCs possess in Latin America. I not only know how to evaluate companies on paper and support PortCos, but I’ve also been in the trenches of creating and spinning out startups myself. This means I can:
Differentiate hype/investment trends from potential industry-disruptive opportunities.
Bridge conversations between founders, scientists, and investors fluently.
Spot scientific, operational, and market risks early and turn them into concrete de-risking strategies that strengthen investment decisions.
Identify, source, and evaluate, deep-tech ventures, and support them through the journey of designing and scaling novel technologies or even first-ok-a-kind (FOAK) systems.
Relevant Experience
IMPACT INVESTMENT
At the Kirchner Impact Foundation I sourced and evaluated 100+ early-stage agtech mexican ventures for a potential catalytic investment of USD 50K. At ATTA Impact Capital I sourced and evaluated 30+ SMEs from Central America and Southern Mexico for potential equity and redeemable equity investments. I am also an angel investor for NanoWeave and Lilliput Technologies.
VENTURE BUILDING & PORTFOLIO SUPPORT
At Deep Science Ventures, I led the creation of two startups in the agriculture, and climate technology sectors: NanoWeave and New Water Labs. I also led the portfolio management for two additional companies: Lilliput Technologies and Aquanzo, conducting quarterly stack rankings, seeking new investors and refining the companies' positioning to accelerate their growth and fundraising readiness.
INVESTMENT READINESS & ENTREPRENEURSHIP SUPPORT
At Village Capital, I have identified and selected +500 high-potential startups across four investment-readiness programs for clients such as Unilever, Moody's, and Johnson & Johnson, with the goal of promoting ESG criteria, sustainability, health equity, and environmental restoration. I have closely worked with 36+ companies to strengthen their fundraising and investment readiness journeys.
RESEARCH & SCIENTIFIC DEVELOPMENT
My scientific background includes extensive training in nanomaterial design for drug and genetic material delivery at the Harvard-MIT Division of Health Sciences and Technology, and wastewater-based epidemiology at Tecnologico de Monterrey, where I developed a nano-structured membrane-based passive sampler to improve sampling procedures for wastewater-based epidemiology (WBE) to monitor SARS-CoV-2, other viral pathogens and contaminants of emerging concern (CECs) in 38+ sites across Mexico.
Relevant Publications
05.
Nanostructured Non-Newtonian Drug Delivery Barrier Prevents Postoperative Intrapericardial Adhesions.
ACS Applied Materials & Interfaces. June 2021.
04.
Antidepressants surveillance in wastewater: Overview extraction and detection.
Case Studies in Chemical and Environmental Engineering. June 2021.
06.
Science students lend their voice at Cancun meet.
The Petri Dish - Malaysian Biotechnology Information Centre. December 2016